Cart
sales@molnova.com
GW779439X
CAS No. 551919-98-3
GW779439X ( —— )
Catalog No. M24539 CAS No. 551919-98-3
GW779439X is an inhibitor of CDK.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 71 | In Stock |
|
| 5MG | 110 | In Stock |
|
| 10MG | 178 | In Stock |
|
| 25MG | 403 | In Stock |
|
| 50MG | 592 | In Stock |
|
| 100MG | 844 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGW779439X
-
NoteResearch use only, not for human use.
-
Brief DescriptionGW779439X is an inhibitor of CDK.
-
DescriptionGW779439X is an inhibitor of CDK.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number551919-98-3
-
Formula Weight454.5
-
Molecular FormulaC22H21F3N8
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC=CC(=N3)C4=C5C=CC=NN5N=C4)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schaenzer A J , Wlodarchak N , Drewry D H , et al. GW779439X and Its Pyrazolopyridazine Derivatives Inhibit the Serine/Threonine Kinase Stk1 and Act As Antibiotic Adjuvants against β-Lactam-Resistant Staphylococcus aureus[J]. other, 2018, 4(10).
molnova catalog
related products
-
(R)-CR8
(R)-CR8 is a potent and selective CDK inhibitor.A delayed systemic post-LFP administration at 3 hours of CR8--a potent second-generation cyclin-dependent kinase (CDK) inhibitor.
-
Senexin-A
A selective inhibitor of CDK8 (IC50=0.28 uM) and CDK19; inhibits CDK8 and CDK19 ATP site binding with Kd50 of 0.83 uM and 0.31 uM, respectively.
-
M2I-1
The first small molecule Mad2 inhibitor that targets the binding of Mad2 to Cdc20; equally potent in inhibiting the binding of F-Mbp1 to Mad2.
